Replies to post #241585 on Biotech Values

[DewDiligence]

PFE/BHVN—Migraine drug, rimegepant approved by EU with the brand name, Vydura (a/k/a Nurtec ODT in US):

https://finance.yahoo.com/news/pfizer-biohaven-vydura-rimegepant-granted-104500600.html

PFE has the ex-US commercial rights to Vydura from a deal with BHVN struck in Nov 2021 (#msg-166695371). The sales could be large enough to move the needle even for a company as large as PFE.